Vanda Pharmaceuticals
VNDA
VNDA
109 hedge funds and large institutions have $682M invested in Vanda Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 26 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
+8
Holders Change %
+7.92%
% of All Funds
2.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
44
Reduced
26
Closed
14
Calls
$32.6M
Puts
$13.6M
Net Calls
+$19M
Net Calls Change
+$22.1M
Top Buyers
| 1 |
DM
1
Deerfield Management
New York
|
$59.3M |
| 2 |
2
Morgan Stanley
New York
|
$20.9M |
| 3 |
KCM
3
Kingdon Capital Management
New York
|
$35.2M |
| 4 |
PAI
4
Palo Alto Investors
Palo Alto,
California
|
$54.2M |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$72.3M |
Top Sellers
| 1 |
SCA
1
Signpost Capital Advisors
New York
|
$11.9M |
| 2 |
JGC
2
J. Goldman & Co
New York
|
$3.97M |
| 3 |
3
Goldman Sachs
New York
|
$2.56M |
| 4 |
4
Bank of New York Mellon
New York
|
$3.06M |
| 5 |
5
Invesco
Atlanta,
Georgia
|
$14.6M |
